Search academic texts

Information × Registration Number 0307U003130, 0106U003512 , R & D reports Title A Muiticenter, Randomized, Double-Blind Placebo-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer. popup.stage_title Дослідження ефективності та систематизація інформації щодо ефективності Дарбепоетину Альфа при лікуванні анемії ракового захворювання. Head Hotko Evgen Stepanovych, Registration Date 22-01-2007 Organization Uzhgorod National University popup.description2 By results of the work (analysis of efficacy comparing to placebo, quantity of red blood cells transfusions) is demonstrated that the study drug (darbepoetin alpha) is effective for treating anemia in patients with cancer who did not receive chemotherapy. Besides the quantity of adverse events and serious adverse events does not exceed analogical index in placebo group.5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close